Who owns Immunomedics?

Key details on Immunomedics (Ticker: IMMU)

Who owns Immunomedics?

Is IMMU a good stock to own? Find out who bought Immunomedics, who sold Immunomedics (IMMU) stock, and who holds a large position in Immunomedics.

Fund Name Number of Shares Share Valuation As Of
FMR 13.81M $51.36M Sept. 30, 2014
BlackRock Fund Advisors 3.13M $11.63M Sept. 30, 2014
Vanguard 3.00M $11.18M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.97M $11.05M Sept. 30, 2014
Deerfield Management Company 2.81M $10.44M Sept. 30, 2014
WCM Investment Management 1.86M $6.94M Sept. 30, 2014
S.A.C. Capital Advisors 1.40M $6.43M Dec. 31, 2013
Sigma Capital Management 1.38M $8.51M Sept. 30, 2013
SUSQUEHANNA INTERNATIONAL 1.33M $4.94M Sept. 30, 2014
STATE STREET CORPORATION 1.28M $4.74M Sept. 30, 2014
RA Capital Management 1000000 $3.65M June 30, 2014
NORTHERN TRUST 986892 $3.67M Sept. 30, 2014
Pine River Capital Management 875000 $2.11M March 31, 2013
Perceptive Advisors 737505 $4.57M Sept. 30, 2013
PanAgora Asset Management 549894 $2.05M Sept. 30, 2014
SPHERA FUNDS MANAGEMENT 534050 $1.99M Sept. 30, 2014
GOLDMAN SACHS 469316 $2.16M Dec. 31, 2013
Bailard 465000 $2.53M June 30, 2013
Geode Capital Management 455479 $1.66M June 30, 2014
TIAA-CREF Investment Management 371124 $1.38M Sept. 30, 2014
DIMENSIONAL FUND ADVISORS 366488 $1.69M Dec. 31, 2013
Wellington Management Company 315608 $1.11M Sept. 30, 2012
Heather K. Mellem, Esq. 312229 $911708 Dec. 31, 2012
GSA Capital Partners 270490 $1.47M June 30, 2013
Millennium Management 266177 $641486 March 31, 2013
Renaissance Technologies 260207 $1.61M Sept. 30, 2013
Oxford Asset Management 251955 $1.37M June 30, 2013
CITADEL ADVISORS 251856 $1.16M Dec. 31, 2013
Zurcher Kantonalbank 250000 $1.15M Dec. 31, 2013

Who sold Immunomedics?

Fund Name Date Sold Number of Shares Sold Share Valuation
UBS AG Dec. 31, 2013 375350 $1.73M
Technical Financial Services Sept. 30, 2011 269397 $862070
Barclays Sept. 30, 2011 259000 $828800
BAM Capital Dec. 31, 2010 262857 $941028